Foreign Insurer

A foreign insurer is an insurance company that is domiciled or incorporated in a country outside the jurisdiction where it operates. For example, an insurer based in France that does business in the United States would be considered a foreign insurer in the U.S.

Here are some key features of a foreign insurer:

  • Regulation: Foreign insurers are subject to the regulatory requirements of the jurisdictions in which they operate. In the U.S., for example, foreign insurers must be licensed by state insurance departments and comply with state insurance regulations.

  • Market access: Foreign insurers may enter new markets by establishing a branch or subsidiary, or by offering insurance products through a licensed intermediary or broker.

  • Cultural differences: Foreign insurers may face cultural differences and language barriers when entering new markets. They may need to adapt their products and marketing strategies to suit local preferences and customs.

  • Competitive landscape: Foreign insurers may face competition from domestic insurers and other foreign insurers operating in the same market. They may need to differentiate themselves through product innovation, customer service, or other factors.

  • Exchange rates: Foreign insurers may be exposed to fluctuations in exchange rates, which can impact their financial performance.

Example:

An example of a foreign insurer is a Canadian insurance company that offers insurance products in the United States through a licensed intermediary. The insurer must comply with U.S. insurance regulations and may need to adapt its products and marketing strategies to suit the U.S. market. It may also face competition from other insurers operating in the U.S. market and be exposed to fluctuations in the Canadian-U.S. exchange rate.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.